The agency said it is giving labs 60 additional days to report private payor rates but is still expecting to launch the new clinical lab fee schedule in 2018.
Freenome, with help from the FDA and reimbursement experts, is conducting studies that answer questions about its technology regulators and payors are interested in.
Poly(GP) proteins could be detected within ALS patients samples and used to determine whether ALS drugs under development are reaching their targets.
The decline reflects the absence of $1.6 million in non-recurring licensing revenue the company received in the year-ago quarter.
The firms will use the FoundationOne assay to characterize tumors and their microenvironment to find predictive measures of response to cancer immunotherapies.
HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.
The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.
In Nature this week: glioma GWAS uncovers new risk loci, and more.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.